3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
6
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Peritoneal Neoplasms
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Multiple Myeloma
1
Lymphoma
1
Hematologic Neoplasms
1
Breast Neoplasms
1
Advanced Solid Tumor
1
Advanced Malignancies
1
Interventions
Radiotherapy
11
Cisplatin
10
Paclitaxel
9
pembrolizumab
7
Fluorouracil
7
Oxaliplatin
6
Irinotecan
6
tislelizumab
5
Cetuximab
5
Docetaxel
4
Radiation
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
Capecitabine
3
Neoadjuvant Therapy
2
Immunohistochemistry
2
Biopsy
2
10-propargyl-10-deazaaminopterin
2
tremelimumab
1
sitravatinib
1
sintilimab
1
regorafenib
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
durvalumab
1
cixutumumab
1
adavosertib
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Squamous Cell Carcinoma
×
1-dodecylpyridoxal
×
Clear all
No trials found.